LAWSUITS NEWS & LEGAL INFORMATION
Infant Teething Tablets Containing Belladonna Recalled
Washington, DC: Hyland's Teething Tablets are being recalled after the Food and Drug Administration (FDA) received reports of "serious adverse events in children taking this product." The teething tablets contain varying amounts of belladonna, which is a potentially toxic ingredient. In addition, the FDA has received reports of children who consumed more tablets than recommended, because the containers do not have child resistant caps.
The FDA reports are consistent with belladonna toxicity. Belladonna can be used as a remedy, but if too much is consumed, it becomes a dangerous poison. Classic signs of Belladonna toxicity include fast heart rate, increased body temperature, dry skin and dry mouth, skin flushing, constipation, decreased urination, agitation, disorientation, hallucinations, and dilated pupils. Drowsiness may also be seen in infants.
In addition, the FDA has received reports of children who consumed more tablets than recommended, because the containers do not have child resistant caps. All lots of Hyland's Teething Tablets are being voluntarily recalled by the company.
Published on Oct-24-10
The FDA reports are consistent with belladonna toxicity. Belladonna can be used as a remedy, but if too much is consumed, it becomes a dangerous poison. Classic signs of Belladonna toxicity include fast heart rate, increased body temperature, dry skin and dry mouth, skin flushing, constipation, decreased urination, agitation, disorientation, hallucinations, and dilated pupils. Drowsiness may also be seen in infants.
In addition, the FDA has received reports of children who consumed more tablets than recommended, because the containers do not have child resistant caps. All lots of Hyland's Teething Tablets are being voluntarily recalled by the company.
Legal Help
If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Published on Oct-24-10
READ MORE Drugs/Medical Settlements and Legal News